title: Role of atrial natriuretic factor in impaired sodium excretion of normocapnic and hypercapnic patients with chronic obstructive lung disease.
abstract: To investigate the mechanisms of sodium retention in patients with chronic obstructive lung disease (COLD), we examined the renal and hormonal responses to volume expansion with isotonic saline and to infusion of atrial natriuretic factor (ANF) in 10 hypercapnic (PaCO2 52 +/- 2 mm Hg) and 12 normocapnic patients (PaCO2 39 +/- 1 mm Hg). Sodium excreted within 4 h of loading (expressed as % sodium load) was 23.5 +/- 2.5% (p < 0.05) in normocapnic and 8.5 +/- 1.5% (p < 0.001) in hypercapnic patients, compared with 32.5 +/- 3.0% in 11 age-matched control subjects. Sodium excretion and renal blood flow correlated negatively with arterial PCO2 and positively with FEV1. Basal plasma ANF concentrations were 72 +/- 5 pg/ml in controls, 100 +/- 14 pg/ml in normocapnic patients, and 230 +/- 52 pg/ml in hypercapnic patients (p < 0.001). Plasma renin activity and aldosterone did not differ between groups. In response to volume expansion, plasma ANF increased in both normocapnic and controls (with a greater increase in normocapnic patients) but remained unchanged in hypercapnic patients. Exogenous ANF increased glomerular filtration rate, renal plasma flow, natriuresis, and diuresis in both groups of patients. Patients with COLD have depressed renal function that appears unrelated to activation of the renin-angiotensin-aldosterone system. An increased secretory response of ANF to volume expansion may help to maintain volume homeostasis in normocapnic patients, while a blunted secretory response of ANF may contribute to sodium retention in hypercapnic patients.
authors.affiliation: Département de Physiologie, Hôpital Henri Mondor, Créteil, France.
authors.forename: S
authors.initials: S
authors.lastname: Adnot
authors.forename: S
authors.initials: S
authors.lastname: Sediame
authors.forename: C
authors.initials: C
authors.lastname: Defouilloy
authors.forename: P
authors.initials: P
authors.lastname: Andrivet
authors.forename: I
authors.initials: I
authors.lastname: Viossat
authors.forename: C
authors.initials: C
authors.lastname: Brun-Buisson
authors.forename: P E
authors.initials: PE
authors.lastname: Chabrier
authors.forename: D
authors.initials: D
authors.lastname: Laurent
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D009320:Atrial Natriuretic Factor / Q000008:administration & dosage / Q000502:physiology*; D002245:Carbon Dioxide / Q000097:blood*; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006935:Hypercapnia / Q000097:blood / Q000453:epidemiology / Q000503:physiopathology*; D007260:Infusion Pumps; D016018:Least-Squares Analysis; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000453:epidemiology / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009318:Natriuresis / Q000187:drug effects / Q000502:physiology*; D017595:Renal Plasma Flow / Q000187:drug effects / Q000502:physiology
chemical_list: D002245:Carbon Dioxide; D009320:Atrial Natriuretic Factor